Exactly, they wouldn't be hiring anyone if there was still hurdles to overcome. Would have been nice if they mentioned the tox study in the announcement and explained the delay or ETA.
- Forums
- ASX - By Stock
- NSB
- Ann: Key Executive Appointments to Support Clinical Studies
Ann: Key Executive Appointments to Support Clinical Studies, page-5
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.205M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 214285 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 75583 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 214285 | 0.035 |
2 | 117147 | 0.034 |
3 | 85800 | 0.033 |
2 | 225000 | 0.032 |
1 | 33332 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 75583 | 1 |
0.040 | 8000 | 1 |
0.041 | 83335 | 1 |
0.042 | 125000 | 3 |
0.043 | 200000 | 1 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online